Scott R - Search Results

1

Shand B, Elder P, Scott R, Frampton C, Willis J. Shand B, et al. Among authors: scott r. Clin Chem Lab Med. 2006;44(10):1264-8. doi: 10.1515/CCLM.2006.227. Clin Chem Lab Med. 2006. PMID: 17032140

2

Comparison of plasma adiponectin levels in New Zealand Maori and Caucasian individuals.

Shand B, Elder P, Scott R, Poa N, Frampton CM. Shand B, et al. Among authors: scott r. N Z Med J. 2007 Jun 29;120(1257):U2606. N Z Med J. 2007. PMID: 17632596

3

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study.

Lewis JG, Shand BI, Frampton CM, Elder PA, Scott RS. Lewis JG, et al. Clin Biochem. 2008 Sep;41(13):1034-8. doi: 10.1016/j.clinbiochem.2008.06.002. Epub 2008 Jun 13. Clin Biochem. 2008. PMID: 18588869

4

Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance.

Shand BI, Scott RS, Elder PA, George PM. Shand BI, et al. Among authors: scott rs. Diabetes Obes Metab. 2003 Sep;5(5):349-53. doi: 10.1046/j.1463-1326.2003.00279.x. Diabetes Obes Metab. 2003. PMID: 12940874

5

Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins.

Plant S, Shand B, Elder P, Scott R. Plant S, et al. Among authors: scott r. Diab Vasc Dis Res. 2008 Jun;5(2):102-8. doi: 10.3132/dvdr.2008.017. Diab Vasc Dis Res. 2008. PMID: 18537097 Free article.

6

Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance.

Lewis JG, Shand BI, Elder PA, Scott RS. Lewis JG, et al. Diabetes Res Clin Pract. 2008 Apr;80(1):e13-5. doi: 10.1016/j.diabres.2007.12.002. Epub 2008 Jan 14. Diabetes Res Clin Pract. 2008. PMID: 18194820

7

Considerable temporal variability in glucose reference curves in humans for a year period.

Wallace AJ, Eady SL, Scott RS, Willis JA, Frampton CM. Wallace AJ, et al. Nutr Res. 2008 Aug;28(8):495-500. doi: 10.1016/j.nutres.2008.05.006. Nutr Res. 2008. PMID: 19083451

8

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.

Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS. Elmslie JL, et al. Among authors: scott rs. Aust N Z J Psychiatry. 2009 Jan;43(1):53-60. doi: 10.1080/00048670802534341. Aust N Z J Psychiatry. 2009. PMID: 19085528

9

Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.

Shand B, Scott R, Connolly S, Clarke R, Baker J, Elder P, Frampton C, Yeo J. Shand B, et al. Among authors: scott r. Diabetes Obes Metab. 2007 Jul;9(4):540-7. doi: 10.1111/j.1463-1326.2006.00635.x. Diabetes Obes Metab. 2007. PMID: 17587396 Clinical Trial.

10

Plasma sex hormone-binding globulin rather than corticosteroid-binding globulin is a marker of insulin resistance in obese adult males.

Lewis JG, Shand BI, Elder PA, Scott RS. Lewis JG, et al. Among authors: scott rs. Diabetes Obes Metab. 2004 Jul;6(4):259-63. doi: 10.1111/j.1462-8902.2004.00343.x. Diabetes Obes Metab. 2004. PMID: 15171749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,560 results

Search Page

Filters